Platelet-membrane-biomimetic nanoparticles for targeted antitumor drug delivery

BACKGROUND: Nanoscale drug-delivery systems (DDSs) have great promise in tumor diagnosis and treatment. Platelet membrane (PLTM) biomimetic DDSs are expected to enhance retention in vivo and escape uptake by macrophages, as well as minimizing immunogenicity, attributing to the CD47 protein in PLTM s...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Haijun, Wu, Junzi, Williams, Gareth R., Fan, Qing, Niu, Shiwei, Wu, Jianrong, Xie, Xiaotian, Zhu, Li-Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513513/
https://www.ncbi.nlm.nih.gov/pubmed/31084622
http://dx.doi.org/10.1186/s12951-019-0494-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513513/
https://www.ncbi.nlm.nih.gov/pubmed/31084622
http://dx.doi.org/10.1186/s12951-019-0494-y

Ejemplares similares